Skip to main content
Equibles

Phocas Financial Corp.

Position in ZVRA — Zevra Therapeutics, Inc.

CIK 1356783 ALAMEDA, CA
Back to ZVRA Full portfolio

Position in ZVRA

as of Jun 30, 2026 · filed Jul 31, 2026
Position Value
$4,243,306
+$2,757,484 QoQ
Shares Held
295,907
+85.6% QoQ
Ownership
0.498%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
#32
of 158 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 16% Shared 0% None 84%

Common Shares in ZVRA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Phocas Financial Corp. holds $23,102,138 across 10 Biotechnology names. ZVRA ranks #1 (18.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZVRA
Zevra Therapeutics, Inc.
This page 		295,907 $4,243,306
2 PTCT
Ptc Therapeutics, Inc.
 46,170 $3,766,086
3 NRIX
Nurix Therapeutics, Inc.
 99,589 $2,416,029
4 CYTK
Cytokinetics Inc
 24,634 $2,098,570
5 PTGX
Protagonist Therapeutics, Inc
 16,378 $2,007,615
6 ACAD
Acadia Pharmaceuticals Inc
 77,245 $1,954,298
7 DNLI
Denali Therapeutics Inc.
 71,197 $1,831,186
8 IDYA
IDEAYA Biosciences, Inc.
 48,822 $1,819,595

All Filings in ZVRA

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,243,306 295,907
2026-03-31 $1,485,822 159,423